Silo Pharma Inc
(SILO)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Sales | 18 | 18 | 18 | 18 | 18 |
| Cost of Goods | 2 | 2 | 2 | 2 | 2 |
| Gross Profit | 17 | 17 | 17 | 17 | 17 |
| Operating Expenses | 822 | 1,675 | 967 | 512 | 545 |
| Operating Income | -804 | -1,657 | -949 | -494 | -527 |
| Interest Expense | 2 | 0 | 0 | 0 | 0 |
| Other Income | -101 | -6 | -34 | -164 | -76 |
| Pre-tax Income | -906 | -1,663 | -983 | -658 | -603 |
| Net Income Continuous | -906 | -1,663 | -983 | -658 | -603 |
| Net Income Discontinuous | N/A | N/A | N/A | N/A | -1 |
| Net Income | $-906 | $-1,663 | $-983 | $-658 | $-604 |
| EPS Basic Total Ops | -0.29 | -0.58 | -0.49 | -0.33 | -0.31 |
| EPS Basic Continuous Ops | -0.29 | -0.58 | -0.49 | -0.33 | -0.31 |
| EPS Diluted Total Ops | -0.29 | -0.58 | -0.49 | -0.33 | -0.31 |
| EPS Diluted Continuous Ops | -0.29 | -0.58 | -0.49 | -0.33 | -0.31 |
| EBITDA(a) | $-770 | $-1,657 | $-949 | $-494 | $-527 |